UNSPSC 51333408: Tefludazine

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C22H24F4N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2XUS19W8FE, chemically known as 1-piperazineethanol, 4-(3-(4-fluorophenyl)-2,3-dihydro-6-(trifluoromethyl)-1h-indel-1-yl)-, trans-(+-)- but generally known as tefludazine, which bears US NIH Compound Identifier 71240. European Medicines Agency schedules Tefludazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10867MIG.

UNSPSC 51333408 Tefludazine, a Commodity code, maps to pharmaceutical and medical substance procurement, though the recent state and local opportunity tagged under this code solicits naloxone and drug deactivation systems rather than tefludazine specifically. State and local governments use this code tier to purchase standalone pharmaceutical products and medical countermeasures for public health initiatives. The issuing bodies are primarily county health departments and municipal public health agencies purchasing emergency response and harm-reduction supplies. Contracts typically require quarterly or regular deliveries, electronic bid submission, E-Verify compliance, and insurance coverage including workers' compensation and professional liability. Vendors must be legally authorized to work in the United States and may face audit, inspection, and termination provisions tied to federal compliance standards when funding derives from federal sources such as FEMA.

Seminole County, Florida posted the most recent identified opportunity under this code: IFB60459723LAS, an Invitation for Bid (IFB) for 1,900 units of naloxone and 800 drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid posted June 30, 2026, with a response deadline of July 26, 2023 (the deadline date in the source predates the posting date, suggesting a data quality issue in the source record). Vendors must include all shipping and delivery costs in their proposal and comply with drug-free workplace certification and federal environmental requirements. The contract term is two years with an optional one-year renewal. No explicit set-aside or disadvantaged-enterprise designation is noted. The source identifies no other recent state and local opportunities under this code.